Discover 657 paid clinical trials in Charleston, South Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 657
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
for
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Location: Charleston SC, Beaufort SC, Savannah GA, Augusta GA,
Sponsor: NRG Oncology
Sex: All
Age: 45 - 70
Code: NCT05080673
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Charleston SC, Columbia SC, Jacksonville FL,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase 3, Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
for
Cystic Fibrosis
Location: Charleston SC, Columbia SC, Augusta GA, Chapel Hill NC,
Sponsor: Nicole Hamblett
Sex: All
Age: 12+
Code: NCT06504589
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Location: Charleston SC, Atlanta GA, Delray Beach FL, New York NY,
Sponsor: PROCEPT BioRobotics
Sex: Male
Age: 45+
Code: NCT07650448
Recruiting
Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)
for
Brain Metastases, Cancer (With CNS Involvement)
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT07227610
Phase 2, Recruiting
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
for
Prostate Cancer,
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: Male
Age: 18+
Code: NCT07325721
Phase 2, Recruiting
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Charleston SC, Charlotte NC, Jacksonville FL, Durham NC,
Sponsor: K36 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05651932
Phase 1, Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)